Antimicrobial
Stewardship
Program
at SCGH
Jason Seet
ID/Critical Care Pharmacist
Sir Charles Gairdner Hospital
Background
 All drugs have adverse effects
 Antibiotics have an ‘additional effect’
 Known as ‘collateral damage’
 Refers to the impact of the antibiotic on the
colonising bacterial flora
 Selection of antibiotic resistant
microorganisms
 Patient becomes colonised with resistant
organisms
The dilemma...
 Antibiotics are one of the most important
discoveries in modern medicine..
 However, inappropriate use of
antimicrobials may lead to ‘collateral
damage’
 On the other hand..
 Severe restriction of antibiotics (inadequate
therapy) in seriously ill patients is associated
with increased mortality
??.. Solution
The role of the Antibiotic Stewardship Program is to
strike a balance between appropriately treating
the patient and avoiding the selection of
antibiotic resistant organisms
Role of antimicrobial
stewardship programs (ASP)
 Aim to
 Optimise antimicrobial therapy (PRIORITY)
 Improve overall patient outcome
 Minimise adverse events
 Decrease the risk of development of
antimicrobial resistance
 Reduce treatment related costs
How is this achieved?
To optimise therapy
 Improve selection/choice of antimicrobial – refer
to microorganism, susceptibilities, resistance
patterns, antibiotic spectrum
 Duration (eg: t1/2), overall therapy duration
 Dose – site of infection, drug factors (Vd, Cl,
bioavailability)
 Route of administration (IV vs po)
How is this achieved?
 Reduce antimicrobial costs
 Limit overuse
 Narrow spectrum chosen (avoid inappropriate use)
 Promote active IV to po switch
 Reduce hospital length of stay (minimising
infections due to resistant organisms)
 Minimise adverse events
 TDM
 Dosage adjustments (individualise therapy)
NAUSP 2006-2009 data
Data demonstrating total antibiotic usage amongst hospitals in
Australia
How did SCGH fare in 2009…?
Cefepime
Clindamycin
Ciprofloxacin
Azithromycin
Meropenem
Timentin/Tazocin
Augmentin DF
The podium of shame
Outcome of this high usage..
 Implementation of an Antimicrobial
Stewardship Program (February 2010)
 HAPI (Healthy Antimicrobial Prescribing
Initiative)
 ‘ward-side’ review of restricted antimicrobial
therapy
 Written recommendations documented in notes
HAPI RoundAntimicrobial
Committee
Site-specific
guidelines and
antibiograms
Electronic
decision
support
HAPI rounds
Consists of
ID Pharmacist
ID Physician/Clinical Microbiologist
+/- ID Registrar
+/- Microbiology Registrar
Review of patients on
Restricted antimicrobials
Prolonged course/s of antimicrobials
HAPI rounds
The team will provide advice to the treating
team in regards to most appropriate
antimicrobial therapy
Eg
Cessation of therapy
Change in therapy
Narrow therapy
Broaden therapy
Switch to oral de-escalation
Referral for ID consult
Why we need AMS?
Broad spectrum antimicrobials
commenced
Appropriate therapy
initially
Micro results return
Pathogen identified
Susceptibility results
available
Patient improves..
But still on broad spectrum
antimicrobials
Infection resolved.
Patient still on broad
spectrum antimicrobials
Patient ready for discharge
Broad spectrum IV antimicrobials
changed to broad spectrum
oral antimicrobials
Impact of AMS rounds
SCGH
Ongoing reduced usage
SCGH
HAPI rounds
 4 x week rounds on general wards
 2 x week rounds in ICU and GHDU
 1 weekly round with Haematology team
Soon..
 eReferral option to AMS (HAPI team) for
assistance with antimicrobial choices, de-
escalation of therapy etc
Can we relax…?
Can we relax…?
How can I find out more info?
http://chips.qe2.health.wa.gov.au/projects/HAPI/index.html
Contact your clinical
pharmacist
Link available via DFS
http://dfsprod.hdwa.health.wa.gov.au/LoginPage.aspx
What can YOU do?
 Overuse/abuse of antimicrobials affects
everyone!
 How can you help?
 Request the prescribers to document
antimicrobial indication on chart
 Antimicrobials warranted?
 Encourage the prescriber to request ID
approval for restricted antimicrobials
 Question antimicrobial duration/s
 Encourage IV to oral switch
 Refer patients on prolonged antimicrobials to
the HAPI team or your clinical pharmacist

Antimicrobial stewardship program 2016

  • 1.
    Antimicrobial Stewardship Program at SCGH Jason Seet ID/CriticalCare Pharmacist Sir Charles Gairdner Hospital
  • 2.
    Background  All drugshave adverse effects  Antibiotics have an ‘additional effect’  Known as ‘collateral damage’  Refers to the impact of the antibiotic on the colonising bacterial flora  Selection of antibiotic resistant microorganisms  Patient becomes colonised with resistant organisms
  • 3.
    The dilemma...  Antibioticsare one of the most important discoveries in modern medicine..  However, inappropriate use of antimicrobials may lead to ‘collateral damage’  On the other hand..  Severe restriction of antibiotics (inadequate therapy) in seriously ill patients is associated with increased mortality
  • 4.
    ??.. Solution The roleof the Antibiotic Stewardship Program is to strike a balance between appropriately treating the patient and avoiding the selection of antibiotic resistant organisms
  • 5.
    Role of antimicrobial stewardshipprograms (ASP)  Aim to  Optimise antimicrobial therapy (PRIORITY)  Improve overall patient outcome  Minimise adverse events  Decrease the risk of development of antimicrobial resistance  Reduce treatment related costs
  • 6.
    How is thisachieved? To optimise therapy  Improve selection/choice of antimicrobial – refer to microorganism, susceptibilities, resistance patterns, antibiotic spectrum  Duration (eg: t1/2), overall therapy duration  Dose – site of infection, drug factors (Vd, Cl, bioavailability)  Route of administration (IV vs po)
  • 7.
    How is thisachieved?  Reduce antimicrobial costs  Limit overuse  Narrow spectrum chosen (avoid inappropriate use)  Promote active IV to po switch  Reduce hospital length of stay (minimising infections due to resistant organisms)  Minimise adverse events  TDM  Dosage adjustments (individualise therapy)
  • 8.
    NAUSP 2006-2009 data Datademonstrating total antibiotic usage amongst hospitals in Australia
  • 9.
    How did SCGHfare in 2009…? Cefepime Clindamycin Ciprofloxacin Azithromycin Meropenem Timentin/Tazocin Augmentin DF The podium of shame
  • 10.
    Outcome of thishigh usage..  Implementation of an Antimicrobial Stewardship Program (February 2010)  HAPI (Healthy Antimicrobial Prescribing Initiative)  ‘ward-side’ review of restricted antimicrobial therapy  Written recommendations documented in notes
  • 11.
  • 12.
    HAPI rounds Consists of IDPharmacist ID Physician/Clinical Microbiologist +/- ID Registrar +/- Microbiology Registrar Review of patients on Restricted antimicrobials Prolonged course/s of antimicrobials
  • 13.
    HAPI rounds The teamwill provide advice to the treating team in regards to most appropriate antimicrobial therapy Eg Cessation of therapy Change in therapy Narrow therapy Broaden therapy Switch to oral de-escalation Referral for ID consult
  • 14.
    Why we needAMS? Broad spectrum antimicrobials commenced Appropriate therapy initially Micro results return Pathogen identified Susceptibility results available Patient improves.. But still on broad spectrum antimicrobials Infection resolved. Patient still on broad spectrum antimicrobials Patient ready for discharge Broad spectrum IV antimicrobials changed to broad spectrum oral antimicrobials
  • 15.
    Impact of AMSrounds SCGH
  • 16.
  • 17.
    HAPI rounds  4x week rounds on general wards  2 x week rounds in ICU and GHDU  1 weekly round with Haematology team Soon..  eReferral option to AMS (HAPI team) for assistance with antimicrobial choices, de- escalation of therapy etc
  • 18.
  • 19.
  • 20.
    How can Ifind out more info? http://chips.qe2.health.wa.gov.au/projects/HAPI/index.html
  • 21.
    Contact your clinical pharmacist Linkavailable via DFS http://dfsprod.hdwa.health.wa.gov.au/LoginPage.aspx
  • 22.
    What can YOUdo?  Overuse/abuse of antimicrobials affects everyone!  How can you help?  Request the prescribers to document antimicrobial indication on chart  Antimicrobials warranted?  Encourage the prescriber to request ID approval for restricted antimicrobials  Question antimicrobial duration/s  Encourage IV to oral switch  Refer patients on prolonged antimicrobials to the HAPI team or your clinical pharmacist